Aware for All, the Clinical Research Education Awareness Day, is May 21
On Saturday, May 21, in Boston Massachusetts, the newly formed non-profit organization -- CISCRP -- will be hosting an event called Aware for All to help educate the public about the clinical research process and the role that it plays in public health.
On Saturday, May 21, in Boston Massachusetts, the newly formed non-profit organization -- CISCRP -- will be hosting an event called Aware for All to help educate the public about the clinical research process and the role that it plays in public health. This is the first event ever of its kind to be held nationally -- and globally.
Aware for All's Honorary Co-Chairs are Lt. Governor Kerry Healey and Boston Mayor Thomas Menino. Featured speakers at the event include Dr. Bernard Schwetz, director US Office for Human Research Protections, Dr. Judy Bigby, Brigham & Women's Hospital, Dr. Karen Freund, Boston Medical Center, Dr. Patricia Hibberd, Tufts-New England Medical Center, and Dr. George Demitri, Dana Farber Cancer Institute to name a few.
For more information, visit www.ciscrp.org
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
